BD Closes $275 Million HandyLab Buy; New HAI Platform Will Launch In 2011
This article was originally published in The Gray Sheet
Executive Summary
BD will launch its BD Max molecular diagnostic system in late 2011 or early 2012, combining its existing assays for health care-associated infections with its newly acquired HandyLab Jaguar integrated testing platform technology, according to the company